Conservest Capital Advisors Inc. Sells 486 Shares of VanEck Biotech ETF (NASDAQ:BBH)

Conservest Capital Advisors Inc. lessened its stake in VanEck Biotech ETF (NASDAQ:BBH) by 2.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 19,624 shares of the company’s stock after selling 486 shares during the period. Conservest Capital Advisors Inc. owned about 0.70% of VanEck Biotech ETF worth $3,244,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in BBH. Commonwealth Equity Services LLC boosted its position in shares of VanEck Biotech ETF by 1.8% during the 3rd quarter. Commonwealth Equity Services LLC now owns 28,705 shares of the company’s stock valued at $4,470,000 after purchasing an additional 495 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in shares of VanEck Biotech ETF by 2.9% during the 3rd quarter. Envestnet Asset Management Inc. now owns 21,949 shares of the company’s stock valued at $3,418,000 after purchasing an additional 609 shares in the last quarter. Raymond James Financial Services Advisors Inc. boosted its position in shares of VanEck Biotech ETF by 34.5% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 19,129 shares of the company’s stock valued at $3,162,000 after purchasing an additional 4,909 shares in the last quarter. Valley Wealth Managers Inc. bought a new stake in shares of VanEck Biotech ETF during the 3rd quarter valued at about $2,956,000. Finally, J.P. Morgan Private Wealth Advisors LLC boosted its position in shares of VanEck Biotech ETF by 192.1% during the 3rd quarter. J.P. Morgan Private Wealth Advisors LLC now owns 8,492 shares of the company’s stock valued at $1,322,000 after purchasing an additional 5,585 shares in the last quarter. Institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Stock Up 0.5 %

Shares of VanEck Biotech ETF stock traded up $0.82 on Friday, hitting $155.59. 6,398 shares of the company’s stock traded hands, compared to its average volume of 10,021. The company has a fifty day moving average of $162.08 and a two-hundred day moving average of $159.75. VanEck Biotech ETF has a one year low of $142.51 and a one year high of $171.04.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.